Announcements Trials
Browse Landscape

Status

Completed 51Recruiting 31Unknown 14Active not recruiting 8Terminated 5Not yet recruiting 4Withdrawn 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Trastuzumab 2Taxes 2Paclitaxel 2Fluorouracil 2Cyclophosphamide 2trastuzumab biosimilar HLX02 1tivozanib 1taletrectinib 1palbociclib 1eribulin 1atezolizumab 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tamoxifen 1Tablets 1Specimen Handling 1Receptors, Chimeric Antigen 1Radiotherapy 1PF-05280014 1Ontruzant 1Ogivri 1Neoadjuvant Therapy 1Methotrexate 1Mastectomy, Segmental 1Lisaftoclax 1Interpersonal Psychotherapy 1Interleukin-2 1Injections 1G(M1) Ganglioside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Breast Neoplasms × Blood Specimen Collection × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡